
Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies
Keywords: آکت; Akt; Nucleoside analog; Triciribine; AML; Phase I clinical trial;